Evidence map›Paper›PMID 30548452›Full record

ArticleAging cell2019

Aging differentially modulates the Wnt pro-survival signalling pathways in vascular smooth muscle cells.

Bethan A Brown, Georgia M Connolly, Carina E J Mill, Helen Williams, Gianni D Angelini, Jason L Johnson, Sarah J George

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Observational
  10. CCN proteins: opportunities for clinical studies-a personal perspective.Journal of cell communication and signaling · 2023
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Aneurysm severity is suppressed by deletion of CCN4.Journal of cell communication and signaling · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Bethan A BrownBristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Georgia M ConnollyBristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Carina E J MillBristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Helen WilliamsBristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Gianni D AngeliniBristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Jason L JohnsonBristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Sarah J GeorgeBristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK.ORCID 0000-0002-1426-8257
Bristol Royal Infirmary · GB

Funding

British Heart Foundation FS/13/68/30489British Heart Foundation FS/18/1/33234British Heart Foundation PG/11/19/28827British Heart Foundation PG/13/9/29990British Heart Foundation PG/16/61/32300British Heart Foundation SS/CH/92027/7163Department of Health EME/15/180/55Medical Research Council MR/J015350/1NIHR Biomedical Centre at the University Hospitals Bristol NHS Foundation TrustNIHR Biomedical Research Unit in Cardiovascular MedicineNIHR (National Institute for Health Research)
6 · The paper itself

Abstract

We previously reported pro-survival effects of Wnt3a and Wnt5a proteins in vascular smooth muscle cells (VSMCs). Wnt5a achieved this through induction of Wnt1-inducible signalling pathway protein-1 (WISP-1) consequent to β-catenin/CREB-dependent, TCF-independent, signalling. However, we found that as atherosclerosis advances, although Wnt5a protein was increased, WISP-1 was reduced. We hypothesized this disconnect could be due to aging. In this study, we elucidate the mechanism underlying Wnt3a pro-survival signalling and demonstrate the differential effect of age on Wnt3a- and Wnt5a-mediated survival. We show Wnt3a protein was expressed in human atherosclerotic coronary arteries and co-located with macrophages and VSMCs. Meanwhile, Wnt3a stimulation of primary mouse VSMCs increased β-catenin nuclear translocation and TCF, but not CREB, activation. Wnt3a increased mRNA expression of the pro-survival factor WISP-2 in a TCF-dependent manner. Functionally, β-catenin/TCF inhibition or WISP-2 neutralization significantly impaired Wnt3a-mediated VSMC survival. WISP-2 was upregulated in human atherosclerosis and partly co-localized with Wnt3a. The pro-survival action of Wnt3a was effective in VSMCs from young (2 month) and old (18-20 month) mice, whereas Wnt5a-mediated rescue was impaired with age. Further investigation revealed that although Wnt5a induced β-catenin nuclear translocation in VSMCs from both ages, CREB phosphorylation and WISP-1 upregulation did not occur in old VSMCs. Unlike Wnt5a, pro-survival Wnt3a signalling involves β-catenin/TCF and WISP-2. While Wnt3a-mediated survival was unchanged with age, Wnt5a-mediated survival was lost due to impaired CREB activation and WISP-1 regulation. Greater understanding of the effect of age on Wnt signalling may identify targets to promote VSMC survival in elderly patients with atherosclerosis.

Indexed as

Cellular SenescenceWnt Signaling PathwayAdolescentAdultAnimalsApoptosisAtherosclerosisbeta CateninCCN Intercellular Signaling ProteinsCell SurvivalChildCyclic AMP Response Element-Binding ProteinFrizzled ReceptorsGene Expression RegulationHumansHydrogen Peroxidebeta CateninCCN5 protein, humanCCN Intercellular Signaling ProteinsCyclic AMP Response Element-Binding ProteinFrizzled ReceptorsHydrogen PeroxideRepressor ProteinsRNA, MessengerTCF Transcription FactorsWnt3A ProteinWnt-5a Proteinagingapoptosisatherosclerosisoxidative stressvascular smooth muscle cellWnt

Identifiers

PMID30548452
PMCPMC6351844
OpenAlexW2905471691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.